Grannus Therapeutics
Indianapolis
About Grannus Therapeutics
Grannus Therapeutics is a biotechnology company that focuses on the development of small-molecule inhibitors for specific isoforms of HSP90. The company was founded in 2020 and is headquartered in Indianapolis, Indiana.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Total funding: $1.8M
- Funding stage: Seed
- Last round: Debt Financing (Jan 2024)
- Website: grannustherapeutics.com
- Phone: 317-414-6205
Industries & Categories
Biotechnology, Health Care, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/grannus-therapeutics-148748 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.